Jefferies Financial Group Increases Cronos Group (TSE:CRON) Price Target to C$3.54

Cronos Group (TSE:CRONFree Report) had its price objective increased by Jefferies Financial Group from C$3.23 to C$3.54 in a research note issued to investors on Friday morning, BayStreet.CA reports.

Separately, Sanford C. Bernstein dropped their price objective on shares of Cronos Group from C$2.84 to C$2.82 and set a market perform rating on the stock in a research note on Tuesday, January 30th.

Get Our Latest Research Report on CRON

Cronos Group Price Performance

Shares of CRON stock opened at C$3.99 on Friday. The company has a debt-to-equity ratio of 0.21, a current ratio of 28.19 and a quick ratio of 24.01. The company has a market capitalization of C$1.52 billion, a P/E ratio of -21.00, a P/E/G ratio of 0.12 and a beta of 1.12. The company’s 50-day simple moving average is C$3.52 and its two-hundred day simple moving average is C$3.03. Cronos Group has a one year low of C$2.15 and a one year high of C$4.28.

Cronos Group Company Profile

(Get Free Report)

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

Featured Stories

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with's FREE daily email newsletter.